The Asia-Pacific pharma industry experienced a 1% drop in new job postings in Q2 2024 compared with the previous quarter, with the highest share accounted for by Biocon with 10,170 job postings, according to GlobalData’s analysis of pharma company job postings. GlobalData’s Pharma: Hiring Trends & Signals Q2 2024 report reveals comprehensive insights into hiring patterns, job roles, required skills, geographical trends, and key themes within the pharmaceuticals industry, facilitating anticipation of future workforce needs. Buy the report here.
Notably, Management Occupations jobs accounted for a 22% share of the Asia-Pacific pharma industry’s total new job postings in Q2 2024, rise 20% over the prior quarter.
Management Occupations drive pharma industry hiring activity
Management Occupations, with a share of 22% new job postings, was the occupation with the greatest hiring activity in the Asia-Pacific pharma industry in Q2 2024 , ahead of Healthcare Practitioners and Technical Occupations with a 7% share of new job postings.
The other prominent roles included Computer and Mathematical Occupations with a 4% share in Q2 2024, Food Preparation and Serving Related Occupations with a 4% share and Life, Physical, and Social Science Occupations with a 4% share of new job postings.
Top five companies accounted for 60% of hiring activity
The top five companies, in terms of number of new job postings tracked by GlobalData, accounted for a combined 60% of the overall hiring activity in the Asia-Pacific pharma industry in Q2 2024.
Biocon posted 10,170 jobs in Q2 2024 and registered a growth of 20% over the previous quarter, followed by AstraZeneca with 1,733 jobs and a 7% drop. Novartis, with 1,723 jobs, and Sanofi, with 1,281 jobs, recorded an 85% rise and a 9% rise, respectively, while F. Hoffmann-La Roche recorded a 43% increase with a 1,031 new job postings during Q2 2024.
Regional analysis of hiring in the Asia-Pacific pharma industry, Q2 2024
India held the leading share of the Asia-Pacific pharma hiring activity with a 59.19% share, a 15% increase over Q1 2024. China was next with 23.03%, four-percentage-point down over the previous quarter.
For further understanding of GlobalData's Pharma: Hiring Trends & Signals Q2 2024, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.